Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Asymptomatic Brain Metastases”

36 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 36 results

Testing effectiveness (Phase 2)Ended earlyNCT04610684
What this trial is testing

Chemotherapy and Atezolizumab for Patients With Extensive Stage Small Cell Lung Cancer (SCLC) With Untreated, Asymptomatic Brain Metastases

Who this might be right for
Small-cell Lung CancerBrain Metastases
Jeffrey Clarke 3
Testing effectiveness (Phase 2)Ended earlyNCT04964960
What this trial is testing

Pembro+Chemo in Brain Mets

Who this might be right for
Lung CancerLung Cancer MetastaticBrain Cancer+1 more
John L. Villano, MD, PhD 3
Large-scale testing (Phase 3)Ended earlyNCT02162537
What this trial is testing

Therapeutic Strategies in Patients With Non-squamous Non-small Cell Lung Cancer With Brain Metastases

Who this might be right for
Non-small Cell Lung Cancer MetastaticNon-small Cell Lung CancerAdenocarcinoma of Lung Metastatic to Brain+1 more
Centre Hospitalier Intercommunal Creteil 95
Testing effectiveness (Phase 2)Study completedNCT02866981
What this trial is testing

Observation for Patients With Asymptomatic CNS Metastatic Disease

Who this might be right for
CancerMetastatic Cancer
The Cooper Health System 33
Not applicableLooking for participantsNCT05033691
What this trial is testing

Evaluate the Efficacy of Osimertinib With Early Intervention SRS Treatment Compared to the Continuation of Osimertinib Alone, in Patients With EGFR Mutated NSCLC and Asymptomatic Brain Metastases

Who this might be right for
NSCLCEGFR Gene MutationEGF-R Positive Non-Small Cell Lung Cancer+2 more
Hadassah Medical Organization 162
Testing effectiveness (Phase 2)Looking for participantsNCT06401824
What this trial is testing

Sacituzumab Govitecan and Bevacizumab for NSCLC Brain Metastases

Who this might be right for
NSCLC Stage IVBrain Metastases, Adult
Maastricht University Medical Center 25
Testing effectiveness (Phase 2)Study completedNCT02614794
What this trial is testing

Tucatinib vs. Placebo in Combination With Capecitabine & Trastuzumab in Patients With Advanced HER2+ Breast Cancer

Who this might be right for
HER2 Positive Breast Cancer
Seagen Inc. 612
Testing effectiveness (Phase 2)WithdrawnNCT05180422
What this trial is testing

A Phase I/II Study of AMG 510 in Combination With MVASI in Patients With Advanced, Unresectable or Metastatic KRAS G12C Mutant NSCLC With Asymptomatic Brain Metastasis

Who this might be right for
Non Small Cell Lung Cancer
Criterium, Inc.
Testing effectiveness (Phase 2)Ended earlyNCT00234442
What this trial is testing

Iressa in the Treatment of Brain Metastases From Non Small Cell Lung Cancer

Who this might be right for
Brain NeoplasmsNon Small Cell Lung Cancer
AstraZeneca 47
Large-scale testing (Phase 3)UnknownNCT01130766
What this trial is testing

Asymptomatic Brain Metastasis in Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-small Cell Lung Cancer
Samsung Medical Center 176
Large-scale testing (Phase 3)UnknownNCT01301560
What this trial is testing

Chemotherapy With or Without Radiosurgery for Asymptomatic Oligo Brain Metastasis

Who this might be right for
Nonsmall Cell Lung Cancer
Samsung Medical Center 176
Testing effectiveness (Phase 2)Looking for participantsNCT04348747
What this trial is testing

Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Metastatic Malignant Neoplasm in the BrainMetastatic Triple-Negative Breast Carcinoma+1 more
Roswell Park Cancer Institute 23
Testing effectiveness (Phase 2)UnknownNCT02250846
What this trial is testing

Study of EGFR-TKI to Asymptomatic Brain Metastases of NSCLC

Who this might be right for
Asymptomatic Brain Metastases of Non Small Cell Lung Cancer
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 70
Testing effectiveness (Phase 2)Enrolling By InvitationNCT06250777
What this trial is testing

Efficacy and Safety of T-DXd in HER2-mutant Advanced Lung Cancer Patients With Asymptomatic Brain Metastases

Who this might be right for
Non Small Cell Lung Cancer
Yonsei University 27
Testing effectiveness (Phase 2)Study completedNCT00744900
What this trial is testing

Pemetrexed Plus Cisplatin for Brain Metastasis of Advanced Non - Small Cell Lung Cancer (NSCLC)

Who this might be right for
Lung Cancer
University Hospital, Brest 45
Testing effectiveness (Phase 2)Study completedNCT00508144
What this trial is testing

Single Agent Alimta in Poor Performance Status in Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
M.D. Anderson Cancer Center 64
Testing effectiveness (Phase 2)UnknownNCT05326425
What this trial is testing

Lazertinib in Patients With NSCLC With Asymptomatic or Mild Symptomatic Brain Metastases After Failure of EGFR TKI.

Who this might be right for
Lung Neoplasms
Jin Hyoung Kang 40
Large-scale testing (Phase 3)Looking for participantsNCT05522660
What this trial is testing

Immunotherapy or Targeted Therapy With or Without Stereotactic Radiosurgery for Patients With Brain Metastases From Melanoma or Non-small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung CancerMelanoma
ETOP IBCSG Partners Foundation 180
Testing effectiveness (Phase 2)UnknownNCT00663689
What this trial is testing

Efficacy of Erlotinib for Brain Metastasis of Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung CancerBrain Metastases
Guangdong Provincial People's Hospital 45
Testing effectiveness (Phase 2)UnknownNCT02736513
What this trial is testing

Intracranial Activity of AZD9291 (TAGRISSO) in Advanced EGFRm NSCLC Patients With Asymptomatic Brain Metastases

Who this might be right for
Lung Cancer
Soroka University Medical Center 40
Load More Results